✦ LIBER ✦

Phase I Trial of Oxaliplatin, Infusional 5-Fluorouracil, and Leucovorin (FOLFOX4) With Erlotinib and Bevacizumab in Colorectal Cancer

✍ Scribed by Wells A. Messersmith; Antonio Jimeno; Heather Jacene; Ming Zhao; Piotr Kulesza; Daniel A. Laheru; Yasmin Kahn; Alexander Spira; Janet Dancey; Christine Iacobuzio-Donahue; Ross C. Donehower; Michael Carducci; Michelle A. Rudek; Manuel Hidalgo

Book ID: 119982741
Publisher: CIG Media Group, LP.
Year: 2010
Tongue: English
Weight: 305 KB
Volume: 9
Category: Article
ISSN: 1533-0028
DOI: 10.3816/ccc.2010.n.043

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase III Trial of Cetuximab, Bevacizuma

Phase III Trial of Cetuximab, Bevacizumab, and 5-Fluorouracil/Leucovorin vs. FOLFOX-Bevacizumab in Colorectal Cancer

✍ Leonard Saltz; Suprith Badarinath; Shaker Dakhil; Bryan Bienvenu; W. Graydon Har 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 512 KB

Front-line Bevacizumab in combination wi

Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study

✍ Christos Emmanouilides; Georgia Sfakiotaki; Nikolaos Androulakis; Kostas Kalbaki 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 263 KB

Oxaliplatin/fluorouracil/leucovorin (FOL

Oxaliplatin/fluorouracil/leucovorin (FOLFOX4 and modified FOLFOX6) in patients with refractory or advanced colorectal cancer: post-approval Japanese population experience

✍ Toshio Shimizu; Taroh Satoh; Kenji Tamura; Tomohiro Ozaki; Isamu Okamoto; Masahi 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 259 KB

A Phase II trial of weekly infusional 5-

A Phase II trial of weekly infusional 5-fluorouracil in combination with lowdose leucovorin in patients with advanced colorectal cancer

✍ Naomi B. Haas; Russell J. Schilder; Sherry Nash; Louis M. Weiner; Robert C. Cata 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 444 KB

Leucovorin, fluorouracil, and oxaliplati

Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial

✍ Yamada, Yasuhide; Takahari, Daisuke; Matsumoto, Hiroshi; Baba, Hideo; Nakamura, 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 438 KB

Postoperative chemoradiotherapy in gastr

Postoperative chemoradiotherapy in gastric cancer: a phase I study of radiotherapy with dose escalation of oxaliplatin, 5-fluorouracil, and leucovorin (FOLFOX regimen)

✍ Xin Wang; Yongsheng Wang; Meng Qiu; Qiu Li; Zhi-ping Li; Bing He; Feng Xu; Ya-li 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 177 KB